Fintel reports that on January 10, 2025, Piper Sandler initiated coverage of ResMed (NYSE:RMD) with a Neutral recommendation.
Piper Sandler upgraded Par Pacific (PARR) to Overweight from Neutral with a price target of $25, up from $23. The company’s ...
Piper Sandler raised the firm’s price target on Arhaus (ARHS) to $15 from $14 and keeps an Overweight rating on the shares ...
On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...
The largest of the wildfires ravaging the area shifted direction, triggering more evacuation orders and posing a new challenge to exhausted firefighters.